| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |